Khorana Risk Score for VTE in Cancer Patients
Loading...
References
- Ang Li. Validation of a Risk Score for Cancer-Associated Thrombosis Using Nationwide EHR Data.. JAMA network open, 2025
- Thure Filskov Overvad. Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy.. Blood advances, 2022
- Floris T. M. Bosch. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.. Blood advances, 2020
- M. Carrier. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. The New England Journal of Medicine, 2019
- F. Mulder. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis. Haematologica, 2019
- Nigel S Key. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019
- A. Khorana. Rivaroxaban for Thromboprophylaxis in High‐Risk Ambulatory Patients with Cancer. The New England Journal of Medicine, 2019
- N. Es. The Khorana Score for the prediction of venous thromboembolism in patients with solid cancer: An individual patient data meta-analysis. Blood, 2017
- A. Khorana. Development and validation of a predictive model for chemotherapy-associated thrombosis.. Blood, 2008